Отправить статью по E-mail Mechanisms of Granulocytopoiesis Recovery Stimulation with Filgrastim in Breast Cancer Patients Receiving Chemotherapy
- Авторы: Goldberg V.E.1, Polyakova T.Y.2,3, Popova N.O.1, Vysotskaya V.V.1, Simolina E.I.1, Dudnikova E.A.1, Goncharova N.M.1, Belevich Y.V.1, Tuzikova T.P.2, Goldberg A.V.1, Miroshnichenko L.A.2, Udut E.V.2, Simanina E.V.2, Zyuz’kov G.N.2, Zhdanov V.V.2, Dygai A.M.1
-
Учреждения:
- Research Institute of Oncology, Tomsk Research Medical Center of the Russian Academy of Sciences
- E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk Research Medical Center of the Russian Academy of Sciences
- National Research Tomsk State University
- Выпуск: Том 166, № 1 (2018)
- Страницы: 63-68
- Раздел: Oncology
- URL: https://journals.rcsi.science/0007-4888/article/view/240835
- DOI: https://doi.org/10.1007/s10517-018-4290-8
- ID: 240835
Цитировать
Открытый доступ
Доступ предоставлен
Только для подписчиков
Аннотация
We studied myelotoxicity of modern schemes of chemotherapy for breast cancer (docetaxel/doxorubicin and cyclophosphamide/doxorubicin/5-fluorouracil) towards granulocytopoiesis, the mechanisms determining the differences of hematological effects of these schemes, and the efficiency of correction of the observed changes with granulocyte CSF (filgrastim). Granulocytopoiesis stimulation with filgrastim during the treatment with docetaxel/doxorubicin combination was more pronounced than during cyclophosphamide/doxorubicin/5-fluorouracil therapy. The observed differences were found at all levels of granulocyte lineage organization (central and peripheral), which is related to different effects of the cytostatic substances used in the proposed protocols on the structures controlling hemopoiesis.
Об авторах
V. Goldberg
Research Institute of Oncology, Tomsk Research Medical Center of the Russian Academy of Sciences
Автор, ответственный за переписку.
Email: center@tnimc.ru
Россия, Tomsk
T. Polyakova
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk Research Medical Center of the Russian Academy of Sciences; National Research Tomsk State University
Email: center@tnimc.ru
Россия, Tomsk; Tomsk
N. Popova
Research Institute of Oncology, Tomsk Research Medical Center of the Russian Academy of Sciences
Email: center@tnimc.ru
Россия, Tomsk
V. Vysotskaya
Research Institute of Oncology, Tomsk Research Medical Center of the Russian Academy of Sciences
Email: center@tnimc.ru
Россия, Tomsk
E. Simolina
Research Institute of Oncology, Tomsk Research Medical Center of the Russian Academy of Sciences
Email: center@tnimc.ru
Россия, Tomsk
E. Dudnikova
Research Institute of Oncology, Tomsk Research Medical Center of the Russian Academy of Sciences
Email: center@tnimc.ru
Россия, Tomsk
N. Goncharova
Research Institute of Oncology, Tomsk Research Medical Center of the Russian Academy of Sciences
Email: center@tnimc.ru
Россия, Tomsk
Yu. Belevich
Research Institute of Oncology, Tomsk Research Medical Center of the Russian Academy of Sciences
Email: center@tnimc.ru
Россия, Tomsk
T. Tuzikova
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk Research Medical Center of the Russian Academy of Sciences
Email: center@tnimc.ru
Россия, Tomsk
A. Goldberg
Research Institute of Oncology, Tomsk Research Medical Center of the Russian Academy of Sciences
Email: center@tnimc.ru
Россия, Tomsk
L. Miroshnichenko
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk Research Medical Center of the Russian Academy of Sciences
Email: center@tnimc.ru
Россия, Tomsk
E. Udut
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk Research Medical Center of the Russian Academy of Sciences
Email: center@tnimc.ru
Россия, Tomsk
E. Simanina
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk Research Medical Center of the Russian Academy of Sciences
Email: center@tnimc.ru
Россия, Tomsk
G. Zyuz’kov
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk Research Medical Center of the Russian Academy of Sciences
Email: center@tnimc.ru
Россия, Tomsk
V. Zhdanov
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk Research Medical Center of the Russian Academy of Sciences
Email: center@tnimc.ru
Россия, Tomsk
A. Dygai
Research Institute of Oncology, Tomsk Research Medical Center of the Russian Academy of Sciences
Email: center@tnimc.ru
Россия, Tomsk
Дополнительные файлы
